BPA Call 36C25723A0033-36C25723N0430

Award Date 8/18/23
Potential Completion Date 8/17/24
Potential Value $41K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78229, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Exact Sciences Corporation, a for-profit medical technology company, for Oncotype gene expression breast cancer testing services. The contract, valued at $746,055.36, was awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA). The contract was awarded under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule and has a completion date of May 14, 2027. No set-aside...
This federal contract award is for the Oncotype DX Breast Assay, a gene expression profiling test for breast cancer, awarded to Exact Sciences Corp, through its Exact Sciences Laboratories, LLC division. The contract has a ceiling value of $48,355.44 and is a firm fixed price delivery order under the Medical Laboratory Testing and Analysis Services schedule with the General Services Administration (GSA). The contract was awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S....
This is a firm fixed price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2), a division of the Department of Veterans Affairs (VA), to Exact Sciences Corp for Oncotype DX breast cancer testing services. The contract has a ceiling value of $6,907.92 and a period of performance ending on July 31, 2024. Exact Sciences Corp is a prime contractor that has previously provided cancer testing and diagnostic services to various federal agencies, including the VA, Defense...
This is a firm fixed price contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 to Exact Sciences Corp, Exact Sciences Laboratories, LLC Division, to provide Oncotype DX testing services. The contract has a ceiling value of $12,771.72 and a period of performance through September 30, 2021. Exact Sciences is an experienced federal contractor, having provided a variety of cancer testing and diagnostic services to agencies such as the VA, Defense...
This federal contract award to Exact Sciences Corporation, a for-profit medical technology company, is for the provision of ONCOTYPE DX TESTING services to the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). The contract has a ceiling value of $23,163.84 and is a Delivery Order issued under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. The contract is a Firm Fixed Price arrangement with an ultimate...
This federal contract award to Exact Sciences Corporation, a for-profit medical technology company, is for the provision of Oncotype DX testing services. The contract, valued at $701,268.00, is a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule with the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17. The contract has an ultimate completion date of August 17, 2025. No set-aside...
This is a federal contract award to Exact Sciences Corporation, a for-profit medical technology company, to provide specialized Oncotype genomic-based testing services. The contract, with a ceiling value of $243,771.45, is a delivery order under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 8. The contract does not have a set-aside...
This is a $55,263.36 firm fixed price delivery order awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs (VA) to Exact Sciences Corp for the Oncotype DX Breast Cancer Assay testing service. The contract is part of the VA's Medical Laboratory Testing and Analysis Services master contract, which is a General Services Administration (GSA) Federal Supply Schedule contract. The contract has an ultimate completion date of September 30, 2025 and does not have a...
This federal contract award, valued at $109,342.62, was issued by the Veterans Integrated Service Network 10 (VISN 10) of the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corporation, a medical technology company specializing in cancer diagnostic testing. The contract is for the provision of Oncotype DX genetic testing services to support breast, colon, and prostate cancer care at the Indianapolis, Indiana VA Medical Center. The contract is a Delivery Order placed under the Medical...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 20 of the U.S. Department of Veterans Affairs to Exact Sciences Corp, doing business as Exact, for Oncotype DX Breast Cancer Genomic Reference Lab Services. The contract has a total ceiling value of $69,079.20 and a performance period through December 31, 2023. This award utilizes Exact Sciences' existing Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services...

This federal contract award was issued by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corp for the provision of Oncotype DX breast cancer testing services. The contract has a ceiling value of $41,447.52 and a performance period through August 17, 2024. This award is a call against a Blanket Purchase Agreement (BPA) under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. No set-aside designation was used. Exact Sciences Corp, through its Exact Sciences Laboratories, LLC division, has a history of providing cancer testing and diagnostic services to federal agencies, including the VA, Department of Defense, and others. This contract will support the VA's healthcare programs by delivering specialized breast cancer genomic testing to patients.

Generated 10/9/24, 9:06 AM